Press Releases

2017

April 25, 2017(PDF)
MaxCyte, Inc. to Present Positive Preclinical Data for Sickle Cell Disease
March 14, 2017(PDF)
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement with MaxCyte
March 2, 2017(PDF)
MaxCyte to Present Pre-Clinical CARMA Data at AACR Meeting
January 16, 2017(PDF)
MaxCyte, Inc. to Present at Phacilitate Cell & Gene Therapy World Conference
January 12, 2017(PDF)
MaxCyte, NIH NIAID Study Published in Science Translational Medicine Demonstrates CRISPR-­Cas9 Repair of X-­linked Chronic Granulomatous Disease (CGD) Gene
January 4, 2017 (PDF)
MaxCyte, Inc. to Present Pre-­Clinical Data for Targeted Gene-­Correction in a Rare Disease at Keystone Symposia on Precision Genome Engineering

2016

December 21, 2016 (PDF)
MaxCyte Announces Strategic Immuno-Oncology Collaboration to Advance New Generation of CAR-based Cell Therapies
November 2, 2016 (PDF)
MaxCyte Appoints Executive Vice President, Business and Strategic Development
September 30, 2016 (PDF)
MaxCyte, Inc. to Present at 2016 Cell & Gene Meeting on the Mesa and Biotech Week Boston 2016
September 6, 2016 (PDF)
MaxCyte Bolsters Distributor Network in Asia to Meet Growing Market Demands for MaxCyte STX® and MaxCyte VLX® Transfection Systems
May 17, 2016 (PDF)
MaxCyte Announces a CRADA with US Army Medical Research Institute of Infectious Diseases for an Exploratory Research Collaboration on Rapid Response Medical Countermeasures
April 20, 2016 (PDF)
MaxCyte to Present Gene Editing Results at the American Society of Gene and Cell Therapy Annual Meeting
March 10, 2016 (PDF)
MaxCyte Partner to Present Data at the Inaugural Bioprocess International West Conference
March 9, 2016 (PDF)
MaxCyte to Present Data on Expression and Functionality of Bispecific Antibodies Produced via Transient Transfection
February 24, 2016 (PDF)
MaxCyte Partners to Present Data at Annual Biophysical Society Meeting
January 12, 2016 (PDF)
MaxCyte, Inc. to Present at Biotech Showcase 2016

2015

October 20, 2015 (PDF)
MaxCyte Appoints Spinco Biotech Pvt Ltd. as Distributor in India for the MaxCyte STX® and MaxCyte VLX®
October 13, 2015 (PDF)
MaxCyte to present novel approach to CAR-T for treatment of solid tumors at Biochemical Society in London
September 30, 2015 (PDF)
MaxCyte, Inc. to Present at 2015 Immuno-Oncology Conference
September 22, 2015 (PDF)
MaxCyte to Present New Data on Expression and Functionality of Bispecific Antibodies Produced via Transient Transfection
September 15, 2015 (PDF)
MaxCyte Appoints Chayon Laboratories as Distributor in Korea for the MaxCyte STX® and MaxCyte VLX®
August 3, 2015 (PDF)
MaxCyte to Present Data on the Ability of Flow Electroporation to Streamline Antibody Development and Production
June 11, 2015 (PDF)
MaxCyte Awarded Maryland Stem Cell Research Fund Grant
May 19, 2015 (PDF)
MaxCyte to Present Data on Development of 'Enhanced' Potency Cell Therapy Products
May 6, 2015 (PDF)
MaxCyte and Partners to Present Data at American Society of Gene and Cell Therapy Meeting
May 5, 2015 (PDF)
MaxCyte to Present Data on Achieving 2.7 grams/Liter of Antibody in CHO Cells With Flow Electroporation
April 27, 2015 (PDF)
MaxCyte Appoints Cold Spring Biotech Corp. as Distributor in China, Taiwan, and Hong Kong for the MaxCyte STX® and MaxCyte VLX®
April 21, 2015 (PDF)
MaxCyte and The Johns Hopkins Kimmel Cancer Center Announce Strategic Immuno-Oncology Collaboration to Advance CAR T-cell Therapies
April 15, 2015 (PDF)
MaxCyte to Present at the 2015 Jefferies Immuno-Oncology Summit
March 31, 2015 (PDF)
MaxCyte Publishes Data on Gram/Liter Antibody Production in the Journal of Biomolecular Screening
March 24, 2015 (PDF)
MaxCyte to Present at 3rd Annual Regen Med Investor Day
January 19, 2015 (PDF)
MaxCyte to Present Data Demonstrating the Impact of Flow Transfection on Improving Protein Expression

2014

October 15, 2014 (PDF)
MaxCyte Appoints Executive Vice President of Global Sales
May 13, 2014 (PDF)
Accelerating Product Development: From Transient Transfection to Stable Pools and Stable Clones
March 20, 2014 (PDF)
MaxCyte Introduces Rapid, Automated, Scalable Flow Electroporation-based Technology for Vaccine Development
January 13, 2014 (PDF)
MaxCyte Introduces the 2014 MaxCyte STX® Scalable Transfection System at CHI's 13th Annual PepTalk Conference in Palm Springs

2013

December 4, 2013 (PDF)
MaxCyte Presents Data on Stable Cell Line Generation and Rapid, High Titer Production of Antibodies and Proteins Using Flow Electroporation
November 4, 2013 (PDF)
MaxCyte Presents Scalable Flow Electroporation as a Universal Platform for High Titer Antibody and Protein Production at CHI's PEGS Europe Summit
August 19, 2013 (PDF)
MaxCyte Presents Large Scale Flow Electroporation for Process Development and Bioproduction at CHI's 2013 BioProcessing Summit
June 18, 2013 (PDF)
Gram Scale Transient Antibody Production in CHO Cells with MaxCyte Electroporation
May 20, 2013 (PDF)
MaxCyte Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation
April 29, 2013 (PDF)
MaxCyte Presents Unprecedented CHO-Based Transient Gene Expression Data for Gram Scale Antibody Production and Rapid Stable Cell Line Generation at CHI's 2013 Protein and Antibody Engineering Summit (PEGS).
April 23, 2013 (PDF)
MaxCyte Highlights the Use of Large Scale Transient Transfection for High Throughput Screening in Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
March 27, 2013 (PDF)
MEDINET and MaxCyte announce publication of joint collaboration supporting delivery of enhanced potency immunotherapy technology for treatment of cancer
February 8, 2013 (PDF)
MaxCyte Presents High Performance, CHO-Based Transgene Expression for Gram Scale Antibody Production Using Flow Electroporation at Informa's 2013 Cell Line Development and Engineering Conference
January 21, 2013 (PDF)
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transient Transfection for Streamlining Antibody Development and Production at PepTalk 2013, Booth #307
January 11, 2013 (PDF)
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transfection for Cell‐Based Assays at the SLAS2013 Conference and Exhibition in Orlando, Booth #428
January 4, 2013 (PDF)
MaxCyte Announces a Business & Technical Update at Biotech Showcase™ 2013

2012

December 11, 2012 (PDF)
MaxCyte Highlights High Titer Protein Production Using Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
March 20, 2012 (PDF)
MaxCyte Highlights Gram Scale Protein Production Capability using CHO Transient Transfection in an Upcoming Educational Webinar Presentation
February 13, 2012 (PDF)
MaxCyte Highlights Gram‐Scale Antibody & Protein Production from Transient Transfection of CHO Cells and MaxCyte® VLX™ Large Scale Transfection System Launch
February 6, 2012 (PDF)
MaxCyte Highlights Innovations in Scalable, High‐Throughput Transfection for Cell‐Based Assays & Protein Production at the SLAS2012 Conference and Exhibition in San Diego, Booth #848
January 9, 2012 (PDF)
The MaxCyte VLX Large Scale Transfection System for Protein and Antibody Production is Launched at PepTalk 2012

2011

March 28, 2011 (PDF)
MaxCyte Highlights Innovations in Scalable, High-Throughput Transfection for Cell-Based Assays & Protein Production at the SBS Annual Meeting in Orlando, FL, Booth #812
January 31, 2011 (PDF)
he MaxCyte® STX™ Scalable Transfection System Demonstrated to Improve Drug Discovery Screening at the LabAutomation 2011 Conference in Palm Springs, CA, Booth #590

2010

September 22, 2010 (PDF)
MaxCyte Demonstrates How to Develop and Optimize Scalable Cell Based Assays at the MipTec 2010 Conference in Basel, Stand G16
May 12, 2010 (PDF)
CCS Cell Culture Service GmbH Acquires the MaxCyte® STX™ Scalable Transfection System for Cell Line Development
April 13, 2010 (PDF)
MaxCyte STXpert Users Explain How to Fast Track Cell Based Assay Development at the SBS Annual Meeting in Phoenix, Booth 342
April 09, 2010 (PDF)
MaxCyte Announces Expansion of License with Medinet
January 26, 2010 (PDF)
Improved Optimization and Development of Ion Channels for Cell-Based Assays MaxCyte Webinar with Case Studies from BioFocus

2009

June 16, 2009 (PDF)
MaxCyte Webinar with Case Studies from ChanTest Corporation: Improving Large Scale GPCR and Ion Channel Assays
May 4, 2009 (PDF)
MaxCyte to Present on Development of Novel Tumor-Targeted Enhanced Potency T Cell Immunotherapy at The 15th Annual Meeting of the International Society of Cellular Therapy (ISCT)
April 30, 2009 (PDF)
MaxCyte GT Flow Transfection System Now available to Academic and Clinical Investigators
April 27, 2009 (PDF)
MaxCyte STX Scalable Transfection System for Cell Based Assays in Drug Discovery: Screening Data to be Presented at the 15th Annual SBS Meeting in Lille, France
February 27, 2009 (PDF)
MaxCyte Presents Membrane Protein Expression Data at the Biophysical Society's Ion Channel Meeting
February 17, 2009 (PDF)
MaxCyte Introduces the GT™ Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
January 26, 2009 (PDF)
The MaxCyte® STX™ Scalable Transfection System to be Presented at the Rapid Fire Innovation Session at LabAutomation2009

2008

December 15, 2008 (PDF)
MaxCyte Presents a Panel Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery – LIVE Q&A to Follow
December 4, 2008 (PDF)
MaxCyte to Present Targeted Cancer Immunotherapy Product at 50th Annual Meeting of the American Society of Hematology
November 18, 2008 (PDF)
MaxCyte STX ® Scalable Transfection System Launched in Europe at SMi's Cell-Based Assays Conference in London
November 12, 2008 (PDF)
MaxCyte Hosts LIVE Discussion with Industry Experts on the Challenges in Developing Cell-Based Screening Assays for Drug Discovery
October 22, 2008 (PDF)
The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
October 3, 2008 (PDF)
MaxCyte to Present at AABB Annual Meeting & TXPO 2008 in Montréal, Québec, Canada
October 2, 2008 (PDF)
MaxCyte and Medinet to Present at The 10th International Symposium on Dendritic Cells in Kobe, Japan
September 24, 2008 (PDF)
MaxCyte Debuts the STX Scalable Transfection System at the ACT Assays & Cellular Targets Meeting
August 20, 2008 (PDF)
Medinet Starts Commercialization of Novel Cancer Immunotherapy Technology in Japan Utilizing Maxcyte's Cell Loading System
June 16, 2008 (PDF)
MaxCyte to Present at 2008 BIO International Convention
April 21, 2008 (PDF)
Breakthrough Large Scale Transfection Technology Accelerates Cell-Based Assay Development
April 7, 2008 (PDF)
MaxCyte to Present at BIO-Europe Spring 2008 Conference
February 26, 2008 (PDF)
MaxCyte to Present at the 3rd Annual Stem Cell Summit
February 6, 2008 (PDF)
MaxCyte to Present at the BIO CEO & Investor Conference
January 28, 2008 (PDF)
MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008